Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 3Recruiting 2

Sponsor Class

OTHER 82NIH 41NETWORK 5INDUSTRY 5OTHER_GOV 3UNKNOWN 2

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 1Lymphoid 1

Conditions

Hematologic Neoplasms 2Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 15fludarabine 13Radiotherapy 12Oxaliplatin 12camrelizumab 11Paclitaxel 11Drug Therapy 11S 1 (combination) 10Carboplatin 10Fluorouracil 9Docetaxel 9Blood Specimen Collection 9Bevacizumab 9Radiation 7Pemetrexed 7Nivolumab 7Gemcitabine 7Erlotinib Hydrochloride 7tislelizumab 6Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5XELOX 5Tamoxifen 5Propranolol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × Cytarabine × Clear all
NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase NA Unknown
68 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT05510089 2023-10-10

Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase NA Unknown
62 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02275663 2015-01-06

Azacytidine Plus FLAG for Relapsed or Refractory AML

King Fahad Medical City

Phase 2 Unknown
37 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡